Trump Admin’s Secret Talks With Moscow ‘Fruitless’ As Putin Boasts Troops Advancing ‘Along Entire Frontline’ In Thursday comments President Trump condemned what he called Russia’s “disgusting” strikes on the Ukrainian capital from the night prior, which left 28 dead according to the continually rising death toll, after emergency crews have been picking through rubble of a […]
‘Too Little Too Late’ – Trump Rages Amid The Post-Payrolls Carnage… Weaker than expected job gains combined with rising unemployment rates and massively negative revisions have sent rate-cut odds soaring with September now priced around 75%… 2025 cut expectations are now back above 50bps (and 2026 is fading modestly)… This has helped smash Treasury yields
‘Too Little Too Late’ – Trump Rages Amid The Post-Payrolls Carnage… Read More »
Jobs Shocker: July Payrolls Far Below Estimates, Follow Massive Revisions Lower Heading into today’s jobs report, sentiment had seen a surprising boost in recent days, with the whisper number rising from just about 110K back to 125K, or where it started the month of July. Well, the optimism proved to be very, very wrong, because
Jobs Shocker: July Payrolls Far Below Estimates, Follow Massive Revisions Lower Read More »
Where’s Your TACO Now: Futures Slide, Global Markets Tumble After Trump Unleashes Harsh Tariffs Global markets and US equity futures extended a selloff as Trump’s sweeping import tariffs sparked renewed fears about the outlook for economic growth amid traders. The MSCI All Country World Index fell for a sixth day, the longest streak since September 2023. As of 8:00am
Trump Vows To Use “Every Tool In The Arsenal” To Force Big Pharma To Cut Drug Prices President Trump’s letter to eighteen of the world’s largest pharmaceutical companies, including AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, and Sanofi, demanding
Trump Vows To Use “Every Tool In The Arsenal” To Force Big Pharma To Cut Drug Prices Read More »
Ukraine Adopts New Anti-Corruption Law: Zelensky Quickly Reverses After Purse Strings Threatened The Zelensky government suffered a black- eye this month, even from the perspective of its Western backers, and the Ukrainian leader has been forced to retreat under pressure. “Ukraine’s parliament approved legislation Thursday restoring the independence of the country’s two main government anti-corruption
Kimberly-Clark Corporation (NASDAQ: KMB) reported its second quarter 2025 earnings results today. Net sales were $4.2 billion, down 1.6% year-over-year. Organic sales growth was 3.9%. Net income attributable to Kimberly-Clark Corporation decreased 6.4% to $509 million compared to last year. GAAP earnings per share of $1.53 was down 5% YoY while adjusted EPS was down 2% to
Key highlights from Kimberly-Clark’s (KMB) Q2 2025 earnings results Read More »
Trump’s Global Tariff Breakdown: Full Country-By-Country Rate List Four months after President Trump stunned the world and rattled global markets by unveiling “Liberation Day” tariff rates, his latest revisions (read here), announced Thursday, and set to go into effect in a week, sparked fresh global equity futures selling early Friday morning. With an average tariff rate of 15%,
Trump’s Global Tariff Breakdown: Full Country-By-Country Rate List Read More »
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2025 earnings results today. Net sales increased 1% year-over-year to $5.1 billion. Organic sales growth was 1.8%. Net income attributable to Colgate-Palmolive Company was $743 million compared to $731 million last year. GAAP EPS rose 2% to $0.91 while adjusted EPS grew 1% to $0.92 YoY.
CL Earnings: All you need to know about Colgate-Palmolive’s Q2 2025 earnings results Read More »
Standard Chartered Sees Higher Long-Term Oil Prices As Shale Costs Rise Oil prices are set to trend higher in the coming years, according to Standard Chartered, as the economics of U.S. shale have shifted significantly, according to OilPrice.com. While crude has hovered near $70/bbl — close to the 20-year average of $73.38 — StanChart notes
Standard Chartered Sees Higher Long-Term Oil Prices As Shale Costs Rise Read More »
